Patent receives dental implant award

FORT LAUDERDALE, Fla., US: Swiss dental implant specialist Patent has been named “Dental Implants Producer of the 12 months in Europe” by means of MedTech Outlook. The award recognises Patent as the primary implant machine to reach a scientifically confirmed bond between peri-implant gentle tissue and a transmucosal implant floor—an development thought to be a decisive step forward within the box of dental implantology.

MedTech Outlook is a number one US-based industry mag that gives in-depth protection of advances in scientific generation. The mag honours corporations creating disruptive scientific applied sciences, and its reputation of Patent’s implant machine recognizes the corporate’s important contribution to the prevention of peri-implantitis.

Comfortable-tissue bond to stop peri-implantitis

The Patent dental implant machine has demonstrated a bond between peri-implant mucosa and an artificial floor—a primary within the historical past of dentistry. A analysis workforce led by means of Prof. Anton Sculean, Dr Peter Schüpbach, Dr Roland Glauser and Prof. Dieter Bosshardt showed this novel biomechanical cellular bond in histological investigations.

Histology of a Patent implant (left) 4 weeks after insertion; because of the soft-tissue bond with the transmucosal implant floor (purple circle), no plaque is visual beneath the soft-tissue stage. (Symbol: Dr Peter Schüpbach)

Patent implants go through a proprietary floor remedy that imparts mucophilic and cell-occlusive houses—improving soft-tissue integration and making a barrier to bacterial ingress—in addition to a floor topography modelled on herbal teeth construction. Consequently, epithelial cells start to develop directly to the transmucosal Patent floor already within the early levels of therapeutic, in the end setting up a bond with it.

At EuroPerio11 in Vienna in Austria, the place those histological effects have been offered all through a symposium, Dr Glauser emphasized that the soft-tissue bond to the transmucosal Patent floor purposes as a dynamic protecting barrier that forestalls plaque from migrating downwards into the tissue and thereby protects it from bacterial invasion. As a result, the chance of irritation and tissue recession is very much diminished, development from mucositis to peri-implantitis is averted, and strong aesthetics are maintained long run.

Peri-implantitis averted in long-term research

The efficacy of this soft-tissue bond has been demonstrated in long-term research. Analysis carried out at universities in Germany and Austria adopted two-piece Patent implants for as much as 9 and 12 years, respectively. The consequences confirmed no circumstances of peri-implantitis, even in high-risk sufferers with periodontitis or systemic illnesses equivalent to most cancers, diabetes or more than one sclerosis or in sufferers with deficient oral hygiene or smoking behavior. An in depth document is to be had at the MedTech Outlook site.